JF-02(JF-02) - _专利_临床

概要

基本信息

药物类型

预防性疫苗、mRNA疫苗

别名

靶点-

作用机制-

治疗领域-

在研适应症-

非在研适应症-

原研机构

JINFA Pharmaceuticals (Nanjing) Co., Ltd.

在研机构

JINFA Pharmaceuticals (Nanjing) Co., Ltd.

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)临床前

特殊审评-

关联

100 项与 JF-02 相关的临床结果

登录后查看更多信息

100 项与 JF-02 相关的转化医学

登录后查看更多信息

100 项与 JF-02 相关的专利（医药）

登录后查看更多信息

1

项与 JF-02 相关的文献（医药）

2006-12-01·Systematic and Applied Microbiology2区 · 生物学

Re-identification of the halotolerant, biosurfactant-producing Bacillus licheniformis strain JF-2 as Bacillus mojavensis strain JF-2

2区 · 生物学

Article

作者: Michael McInerney ; Sung Ok Han ; Kathleen Duncan ; Eleanor Jennings ; David Nagle ; Martha Folmsbee

Bacillus strain JF-2 (ATCC 39307) is a halotolerant, biosurfactant-producing bacterium that was initially described as a member of the species Bacillus licheniformis based on a limited set of phenotypic characteristics. Here, genetic and phenotypic analyses were employed to determine the relationship of Bacillus strain JF-2 to other Bacillus strains. The restriction patterns with AluI and analysis of gyrA and 16S rRNA gene sequences grouped Bacillus strain JF-2 with B. mojavensis(T) and not with B. licheniformis(T). DNA-DNA similarity showed JF-2 was 75% similar to B. mojavensis(T) and only 11% similar to B. licheniformis(T). Both strain JF-2 and B. mojavensis(T) required DNA for anaerobic growth, but B. licheniformis(T) did not. B. mojavensis(T) and strain JF-2 did not grow anaerobically in thioglycollate medium or aerobically with propionate while B. licheniformis(T) grew under these conditions. DNA-DNA similarity, gene sequence data and phenotypic characteristics all support the assignment of JF-2 as a member of the species B. mojavensis.

100 项与 JF-02 相关的药物交易

登录后查看更多信息